Physician profile
Jeremiah Dillon
NPI 1720321540
$3,710.46
in general payments reported to CMS, 2019-2025
13 companies · $1.93 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $878 · 2020: $547 · 2021: $1,111 · 2022: $557 · 2023: $549 · 2024: $65.88 · 2025: $1.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,080.15 | 2019-2023 | Grafix Pl, Stravix Mesh |
| Osiris Therapeutics INC. | $226.04 | 2019 | |
| Organogenesis INC. | $109.77 | 2019 | |
| Biopro, INC. | $64.64 | 2023 | |
| Depuy Synthes Sales INC. | $52.92 | 2020-2021 | |
| Cdc Medical LLC | $44.93 | 2024 | |
| Misonix INC | $36.10 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $22.35 | 2020 | |
| Solventum Corporation | $20.95 | 2024 | V.A.C. Veraflo, Prevena |
| Anika Therapeutics, INC. | $18.66 | 2021 | |
| Horizon Therapeutics Plc | $18.28 | 2022 | |
| Kci USA, INC. | $13.74 | 2020 | |
| Ets Wound Care LLC | $1.93 | 2025 | Mirragen Advanced Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremiah Dillon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.